Tito's latest product is an empty can for a good cause.
, a 16-ounce, double-steel-walled, insulated, refillable can with nothing in it but potential.
That’s right – for $20, you can be the proud owner of a can! While the idea behind the product, according to Taylor Berry, Tito’s Vice President of Brand Marketing, is to give consumers control over their own seltzers – indeed, you can put vodka and other mixers in there , the possibilities are endless.
has been Austin’s independent news source for over 40 years, expressing the community’s political and environmental concerns and supporting its active cultural scene. Now more than ever, we need your support to continue supplying Austin with independent, free press. If real news is important to you, please consider making a donation of $5, $10 or whatever you can afford, to help keep our journalism on stands.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Trump fumes over 'RINO disaster' Vos, 'giveaway' McConnell in latest tiradeEarlier this month Trump pressured Wisconsin Assembly Speaker Robin Vos to overturn the 2020 election, which Vos said was impossible.
Weiterlesen »
Stolen vehicles recovered, ATVs and dirt bikes impounded in latest crackdownPolice said they recovered two stolen vehicles and impounded 11 more in a third operation in their bid to crack down on illegal ATV and dirt bike use.
Weiterlesen »
MLB trade deadline 2022: Live updates, rumors on Juan Soto, news on the latest dealsMajor League Baseball's trade deadline isn't until 6 p.m. ET on Tuesday, but there already have been some big deals made.
Weiterlesen »
Juan Soto Watch: The latest on MLB trade deadline rumor mill and where the Rangers standThe MLB trade deadline is just a few days away, pushed back from its usual July 31 cut-off and moved to Aug. 2 due to the lockout that delayed the start of...
Weiterlesen »
Biden's latest COVID-19 'rebound' case has researchers evaluating link to anti-viral drugHealth experts say during clinical trials, rebound cases happened in only 1 to 2% of people.
Weiterlesen »